Interpace Diagnostics Announces Coverage of Thyroid Test by Oxford Health Plans
16 août 2017 08h30 HE
|
Interpace Diagnostics Group
PARSIPPANY, N.J., Aug. 16, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...
Interpace Diagnostics Group Reports Second Quarter 2017 Financial Results, Business Progress and Recent Accomplishments
10 août 2017 09h50 HE
|
Interpace Diagnostics Group
Net Revenue Grew 7% Over the Prior Year Comparable Quarter and 11% Over the First Quarter of 2017 Raised Over $22 Million in Capital in Past 6 MonthsEliminated All Long Term Debt and Related Royalties...
Interpace Diagnostics to Host Conference Call and Webcast to Discuss Second Quarter 2017 Financial Results on Thursday August 10, 2017
09 août 2017 16h05 HE
|
Interpace Diagnostics Group
PARSIPPANY, N.J., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...
Interpace Diagnostics Launches Product Extension at World Conference on Thyroid Cancer
01 août 2017 08h00 HE
|
Interpace Diagnostics Group
BOSTON, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or the “Company”), a fully integrated commercial company that provides clinically useful...
Interpace Diagnostics Announces Cigna Coverage of ThyGenX®
27 juil. 2017 08h00 HE
|
Interpace Diagnostics Group
PARSIPPANY, N.J., July 27, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...
Interpace Diagnostics Joins the Fight Against Pancreatic Cancer at the Pittsburgh PurpleStride Event
13 juil. 2017 14h19 HE
|
Interpace Diagnostics Group
PARSIPPANY, N.J., July 13, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics (Nasdaq:IDXG) has joined the Pancreatic Cancer Action Network (PanCAN) to raise critical funds and awareness for pancreatic...
Interpace Diagnostics Announces National Contract with Aetna
28 juin 2017 08h15 HE
|
Interpace Diagnostics Group
PARSIPPANY, N.J., June 28, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...
Interpace Diagnostics Announces Coverage of Thyroid Test By Premera Blue Cross
26 juin 2017 08h15 HE
|
Interpace Diagnostics Group
PARSIPPANY, N.J., June 26, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...
Interpace Diagnostics Announces Closing of $13.7 Million Public Offering
21 juin 2017 11h40 HE
|
Interpace Diagnostics Group
PARSIPPANY, N.J., June 21, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (Nasdaq:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...
Interpace Diagnostics Announces Pricing of $13.7 Million Underwritten Public Offering of Common Stock and Common Warrants
16 juin 2017 09h00 HE
|
Interpace Diagnostics Group
PARSIPPANY, N.J., June 16, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (Nasdaq:IDXG) (“Interpace” or “the Company”), a fully integrated commercial company that provides clinically...